CLIFTON-FINE HOSPITAL
1. Target Overview & Investment Thesis
CLIFTON-FINE HOSPITAL is a 20-bed community hospital in ST. LAWRENCE, NY with $9.0M in net patient revenue and a -24.9% operating margin. The hospital serves a payer mix of 17.4% Medicare, 0.0% Medicaid, and 82.6% commercial.
Thesis: Turnaround. Our ML models identify $673K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -24.9% to -17.5% (+744bps).
| Net Revenue HCRIS | $9.0M |
| Current EBITDA COMPUTED | $-2.3M |
| Operating Margin COMPUTED | -24.9% |
| Occupancy HCRIS | 63.9% |
| Revenue / Bed COMPUTED | $452K |
| Net-to-Gross HCRIS | 93.5% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
NY has 196 Medicare-certified hospitals with a median operating margin of -17.5%. The target's margin of -24.9% places it below the state median. Among 28 size-comparable peers (10-40 beds), the median margin is -16.0%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (10-40), prioritizing same-state peers. 28 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CLIFTON-FINE HOSPITAL (Target) | NY | 20 | $9.0M | -24.9% |
| NEW YORK EYE AND EAR INFIRMARY | NY | 15 | $112.8M | -28.0% |
| CLAXTON HEPBURN MEDICAL CENTER | NY | 38 | $106.9M | -16.0% |
| ALICE HYDE MEDICAL CENTER | NY | 40 | $79.7M | -29.4% |
| LEWIS COUNTY GENERAL HOSPITAL | NY | 25 | $70.3M | -17.6% |
| CARTHAGE AREA HOSPITAL | NY | 25 | $59.4M | -12.3% |
| SUNNYVIEW HOSPITAL AND REHABIL | NY | 17 | $56.6M | -9.4% |
| COMMUNITY MEMORIAL HOSPITAL | NY | 25 | $53.2M | -6.7% |
| MASSENA MEMORIAL HOSPITAL | NY | 25 | $48.4M | -14.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $673K (744bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $190K | +210bp | 18mo |
| Denial Rate Reduction | 12.0% | 6.5% | $182K | +202bp | 12mo |
| Cost to Collect | 4.5% | 2.5% | $181K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $110K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +11bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-2.3M |
| + RCM Uplift | +$673K |
| Pro Forma EBITDA | $-1.6M |
| Current Margin | -24.9% |
| Pro Forma Margin | -17.5% |
| WC Released (1x) | $347K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-3.5M | $-8.2M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-3.5M | $-10.1M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-3.1M | $-9.0M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-3.1M | $-10.7M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-3.8M | $-10.4M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-3.8M | $-12.7M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 28 hospitals with 10-40 beds
- Same-state prioritization (n=29)
- Comp margins: P25=-27.7% / P50=-16.0% / P75=-8.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.